Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/5/2023 | $4.00 | Buy | ROTH MKM |
| 3/9/2022 | $13.00 → $2.50 | Hold | Canaccord Genuity |
| 3/9/2022 | $11.00 → $2.00 | Sector Perform | RBC Capital |
| 8/20/2021 | $35.00 → $9.00 | Market Perform → Underperform | Cowen & Co. |
| 8/20/2021 | $15.00 | Buy → Neutral | B. Riley Securities |
Q3 Revenue of $2.6 million, down 31% year-over-year Q3 Operating loss of $(5.1) million, a 26% increase year-over-year Q3 Adjusted EBITDA of $(3.3) million, a 24% decline year-over-year Company announces expansion of behavioral health solutions with Sentara Health for Commercial and Marketplace members Company begins enrollment of new members into Ontrak's WholeHealth+ solution under a new contract with a large northeast regional health plan and announces expansion of its services with Ontrak Quality solution Company announces a reverse split of its common stock at a ratio of 1-for-15, which was effective at 12:01 a.m. Eastern Time on September 23, 2024 Company to Host Co
Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2024 on Wednesday, November 13, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events/. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes
Ontrak, Inc. (NASDAQ:OTRK), a leading AI-powered and tech-enabled behavioral healthcare company, today announced an expansion of its strategic partnership with its most recently signed customer, a large, regional health plan in the Northeast. The expanded engagement uses Ontrak Health's recently launched Ontrak Quality solution to focus on behavioral health metrics according to Healthcare Effectiveness Data and Information Set (HEDIS). The goals are to enhance patient outcomes and help the health plan achieve national quality benchmarks. Ontrak Quality will broaden access to services for Commercial, Medicaid and HARP members not enrolled in the WholeHealth+ program, identified by the healt
ROTH MKM initiated coverage of Ontrak with a rating of Buy and set a new price target of $4.00
Canaccord Genuity reiterated coverage of Ontrak with a rating of Hold and set a new price target of $2.50 from $13.00 previously
RBC Capital reiterated coverage of Ontrak with a rating of Sector Perform and set a new price target of $2.00 from $11.00 previously
Q3 Revenue of $2.6 million, down 31% year-over-year Q3 Operating loss of $(5.1) million, a 26% increase year-over-year Q3 Adjusted EBITDA of $(3.3) million, a 24% decline year-over-year Company announces expansion of behavioral health solutions with Sentara Health for Commercial and Marketplace members Company begins enrollment of new members into Ontrak's WholeHealth+ solution under a new contract with a large northeast regional health plan and announces expansion of its services with Ontrak Quality solution Company announces a reverse split of its common stock at a ratio of 1-for-15, which was effective at 12:01 a.m. Eastern Time on September 23, 2024 Company to Host Co
Ontrak Health (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced it will report financial results for the third quarter 2024 on Wednesday, November 13, 2024, after market close. Company management will host a corresponding conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Conference Call & Webcast Details The conference call can be accessed by registering online for dial-in information or via live audio webcast at: https://ontrakhealth.com/investors/presentations-events/. Participants interested in dialing in to the conference call are requested to register a day in advance or at a minimum 15 minutes
Q2 Revenue of $2.5 million, down 17% year over year Q2 Operating loss of $(4.0) million, a 13% improvement year over year Q2 Adjusted EBITDA of $(3.3) million, an 8% decline year over year Company announces new contract with large northeast regional health plan Company announces final results of a formal evaluation showing achievement of $721 per member per month cost savings for a prominent health plan's members Company announced the adoption of the Comprehensive Healthcare Integration (CHI) framework into its care delivery model Company to Host Conference Call at 4:30 pm ET Today Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technol
SC 13G/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
SC 13D/A - Ontrak, Inc. (0001136174) (Subject)
Ontrak, Inc. (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of James Messina as a non-Executive Director to its board. Mr. Messina is a Co-Founder and General Partner of Seattle Hill Ventures and x4 Capital Partners, which invest in, and support, startup ventures by providing business development, marketing, operating and technology support. Previously, Mr. Messina was the Executive Vice President and Chief Operating Officer for Premera Blue Cross ("Premera"). He was responsible for effectively servicing the needs of Premera's customers with oversight of all operational functions, from customer serv
Mental Healthcare Leader and Harvard Medical School Faculty Member Joins Ontrak Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of Dr. Robert Accordino as Ontrak's Chief Medical Officer, effective September 27, 2021. Dr. Accordino joins Ontrak from Quartet Health where he served as the company's most senior clinician and Chief Mental Health Officer. He practices psychiatry and is on the faculty of Harvard Medical School and Massachusetts General Hospital. Dr. Accordino will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "Dr. Accordino's reputation in
Former Accenture and KPMG Healthcare Expert Brings Proven Leadership Experience In Behavioral Health Digital Transformation Ontrak, Inc (NASDAQ:OTRK) ("Ontrak" or the "Company"), a leading AI-powered and telehealth-enabled healthcare company, today announced the appointment of Arik Hill as Ontrak's first Chief Information Officer, effective August 30, 2021. Mr. Hill will report to Jonathan Mayhew, CEO, who joined Ontrak from CVS Health earlier this year. "As Chief Information Officer at The New York Foundling, a fast growing organization that collaborates with over 250,000 behavioral healthcare partners across the country, Arik led the development of digital platforms and applications th
Ontrak, Inc (NASDAQ:OTRK), a leading AI-powered and technology-enabled behavioral healthcare company, announces the adoption of the Comprehensive Healthcare Integration (CHI) framework into its care delivery model. This advances Ontrak Health's commitment to delivering high quality, integrated, whole person care. The CHI model represents the most comprehensive clinical framework for integrating physical health, behavioral health, and social determinants of health within care delivery.
Gainers Kineta (NASDAQ:KA) shares moved upwards by 28.5% to $0.67 during Friday's after-market session. The company's market cap stands at $8.1 million. iSpecimen (NASDAQ:ISPC) stock moved upwards by 13.99% to $0.57. The market value of their outstanding shares is at $5.6 million. ENDRA Life Sciences (NASDAQ:NDRA) shares moved upwards by 11.0% to $0.12. The market value of their outstanding shares is at $1.9 million. Brainstorm Cell (NASDAQ:BCLI) shares increased by 9.08% to $0.51. The market value of their outstanding shares is at $35.9 million. Bullfrog AI Hldgs (NASDAQ:BFRG) stock increased by 7.53% to $2.71. The company's market cap stands at $21.2 million. Can Fite Biofarma (AMEX:
10-Q - Ontrak, Inc. (0001136174) (Filer)
8-K - Ontrak, Inc. (0001136174) (Filer)
8-K - Ontrak, Inc. (0001136174) (Filer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)
4 - Ontrak, Inc. (0001136174) (Issuer)